SCHEMBL5733933

SCHEMBL5733933

Oc1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMK2D Q13557 6/20 0.71
ABL1 P00519 2/20 0.69
BCR P11274 2/20 0.69
PRKCA P17252 1/20 0.69
PRKCD Q05655 1/20 0.69
PLK1 P53350 2/20 0.66
CDK2 P24941 4/20 0.65
CDK1 P06493 2/20 0.65
SMG1 Q96Q15 2/20 0.65
MAPT P10636 2/20 0.65
CDK4 P11802 2/20 0.65
NPC1 O15118 1/20 0.65
CCNT1 O60563 1/20 0.65
CCNB1 P14635 1/20 0.65
XBP1 P17861 1/20 0.65
CCNA2 P20248 1/20 0.65
CCND1 P24385 1/20 0.65
CCNE1 P24864 1/20 0.65
MAPK1 P28482 1/20 0.65
MTOR P42345 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3513778 0.88 CAMK2D (0.73) CAMK2DABL1BCRPRKCAPRKCD
SCHEMBL2327902 0.87 CAMK2D (0.67) CAMK2DABL1BCRPRKCAPRKCD
SCHEMBL4899574 0.86 ABL1 (0.76) CAMK2DABL1BCRPRKCAPRKCD
SCHEMBL5732902 0.86 CAMK2D (0.77) CAMK2DABL1BCRPRKCAPRKCD
SCHEMBL4905928 0.86 PLK1 (0.72) CAMK2DABL1BCRPRKCAPRKCD
SCHEMBL2328157 0.86 CAMK2D (0.70) CAMK2DABL1BCRPRKCAPRKCD
SCHEMBL2322029 0.85 CDK2 (0.67) CAMK2DABL1BCRPRKCAPRKCD
SCHEMBL3513988 0.85 CAMK2D (0.75) CAMK2DABL1BCRPRKCAPRKCD
SCHEMBL27116599 0.85 ABL1 (0.62) CAMK2DABL1BCRPRKCAPRKCD
SCHEMBL27116472 0.84 CDK2 (0.57) CAMK2DABL1BCRPRKCAPLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0672042-B1 PHARMACOLOGICALLY ACTIVE PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF NOVARTIS AG (CH) 2006-05-03 EP claimed
US-5705502-A Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof NOVARTIS CORPORATION (US) 1998-01-06 US claimed
EP-0672042-A1 PHARMACOLOGICALLY ACTIVE PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF Novartis AG (CH) 1995-09-20 EP claimed
WO-1995009851-A1 PHARMACOLOGICALLY ACTIVE PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF CIBA-GEIGY AG (CH) 1995-04-13 WO claimed
EP-0672042-B1 PHARMACOLOGICALLY ACTIVE PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF NOVARTIS AG (CH) 2006-05-03 EP disclosed
US-5705502-A Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof NOVARTIS CORPORATION (US) 1998-01-06 US disclosed
EP-0672042-A1 PHARMACOLOGICALLY ACTIVE PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF Novartis AG (CH) 1995-09-20 EP disclosed
WO-1995009851-A1 PHARMACOLOGICALLY ACTIVE PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF CIBA-GEIGY AG (CH) 1995-04-13 WO disclosed